Call Us For Easy
Confidential Assistance
503-506-0101
It only takes 5 minutes to get started
Posted on: January 1st, 2026 by writer

For many people, cannabis is seen as a harmless way to relax, manage pain, or even treat nausea. But what happens when the drug meant to calm your stomach starts causing severe, uncontrollable vomiting instead?
Cannabis Hyperemesis Syndrome (CHS) is a little-known but increasingly common condition affecting long-term marijuana users—particularly those consuming high-potency products like concentrates and vapes. Despite cannabis being widely prescribed as an anti-nausea medication, chronic use can trigger a dangerous paradox: severe, cyclical vomiting that only worsens with continued use.
In Oregon, where recreational cannabis has been legal since 2015 and high-THC products dominate the market, emergency departments are seeing a dramatic rise in CHS cases. Many patients spend hours in scalding hot showers trying to find relief, unaware that their marijuana habit is the root cause.
This article explores the science behind CHS, why it’s becoming more prevalent, and why residential treatment programs like Pacific Ridge are uniquely positioned to help patients break the cycle of chronic cannabis use before it leads to life-threatening complications.
CHS represents a medical paradox where the same compound used to treat nausea—THC—becomes the cause of severe, recurring vomiting episodes when used chronically at high doses.
The Endocannabinoid System (ECS): At low doses, THC interacts with CB1 receptors in the brain to suppress nausea and vomiting. This is why cannabis is prescribed for chemotherapy patients. The body’s endocannabinoid system plays a vital role in regulating homeostasis, including gastrointestinal motility and nausea control.
The Biphasic Effect: With chronic, high-dose use, CB1 receptors in the gut become desensitized or dysregulated, leading to gastroparesis (delayed stomach emptying) and severe vomiting. What works as medicine in small doses becomes poison in sustained, high quantities.
Why It’s Misunderstood: Patients often don’t connect their symptoms to cannabis use. Many increase consumption, believing it will help—creating a dangerous feedback loop. This “learned behavior” stems from the initial relief cannabis provided, making it counterintuitive that the same substance now causes their distress.
The “Scromiting” Phenomenon: Emergency medicine professionals coined the term “scromiting” (screaming and vomiting) to describe the intense abdominal pain and violent retching episodes characteristic of CHS. The combination of debilitating pain and uncontrollable vomiting creates a medical emergency that often leaves patients and physicians baffled.

CHS doesn’t appear overnight. It develops in three distinct phases, often over months or years, with symptoms escalating if cannabis use continues.
Duration: Months to years
During this initial phase, patients experience morning nausea, abdominal discomfort, and fear of vomiting. The symptoms are mild enough that most people continue their daily routines, and crucially, they maintain or increase cannabis use, believing it helps manage the nausea. Eating patterns remain relatively normal during this phase, making it easy to dismiss the symptoms as unrelated to cannabis consumption.
Duration: 24-48 hours (can persist with continued use)
This phase marks the acute medical emergency. Patients experience intense, uncontrollable vomiting known as “paroxysms”—sudden, violent episodes that occur without warning. Severe abdominal pain accompanies the vomiting, along with rapid dehydration and potentially dangerous weight loss.
The “Hot Shower Test”: Patients compulsively take scalding showers or baths for temporary relief—a pathognomonic (uniquely characteristic) sign of CHS. This behavior, termed “hydrophilia” in medical literature, involves spending hours per day in hot water seeking relief. Some patients report taking 10 or more showers daily, often at temperatures hot enough to cause skin burns.
Duration: Days to months
The recovery phase has one critical requirement: complete cessation of cannabis use. When use stops, symptoms resolve and normal eating patterns return. However, this phase comes with an important warning: re-exposure to cannabis almost always triggers immediate relapse of symptoms.
A 23-year-old male with 5 years of daily cannabis use visited the ER six times over two years with severe vomiting and abdominal pain. He took up to 10 hot showers daily. After multiple expensive, invasive tests—CT scans, endoscopy, colonoscopy—all returned normal, he was misdiagnosed with viral gastroenteritis and anxiety. Only after specific questioning about cannabis use and hot shower habits was CHS diagnosed. Symptoms resolved within 48 hours of stopping use—but returned immediately when he relapsed three months later.
This case illustrates the diagnostic delay that plagues CHS recognition. Patients often undergo unnecessary testing because they don’t disclose cannabis use, or clinicians fail to ask the right questions.

The dramatic increase in cannabis potency over the past 30 years—especially in legal markets like Oregon—is directly correlated with the surge in CHS cases.
In 1995, average THC content in cannabis flower was approximately 4%. By 2010, that average had climbed to 10%, and concentrates entered the market with THC levels between 40-50%. Fast forward to 2021, and flower now averages 15-30% THC, while concentrates—including dabs, waxes, and vapes—regularly exceed 80-90% THC.
Oregon’s mature recreational market prioritizes high-THC strains, with dispensaries competing on potency rather than quality or balance. Concentrates deliver massive boluses of THC, exceeding the body’s tolerance ceiling and rapidly pushing chronic users toward the biological tipping point where CHS develops. Research shows users of high-potency concentrates face significantly higher risk of developing CHS compared to occasional flower users.
Colorado, which legalized recreational cannabis before Oregon, provides a predictive model for what happens in mature legal markets. Studies show Colorado experienced a three-fold increase in cannabis-related vomiting ED visits after legalization. Even more striking, a survey of urban ER patients with frequent cannabis use found 32.9% met diagnostic criteria for CHS, suggesting the condition is vastly underdiagnosed.
Why Pacific Ridge Sees This: Oregon’s unrestricted access to high-potency products creates specific urgency for treatment centers equipped to address CHS-related complications. As the legal market matures and potency continues to climb, residential programs become essential for managing the physical consequences of chronic use.
One of CHS’s most distinctive features is the compulsive need for scalding hot showers. Understanding the science behind this behavior helps differentiate CHS from other vomiting disorders.
TRPV1 (Transient Receptor Potential Vanilloid 1) receptors normally signal heat and pain sensations. They also regulate gastric motility—the movement of the stomach that processes food. Chronic cannabis use downregulates these receptors, disrupting normal digestive function.
Scalding water activates cutaneous (skin) TRPV1 receptors. This sensory input overrides nauseogenic (nausea-causing) signals from the gut to the brain, providing temporary relief—but only while in the hot water. Once the patient leaves the shower, symptoms return, often with increased intensity.
Patients report spending hours per day in hot water, a behavior so specific to CHS that it’s considered a diagnostic criterion. This “hydrophilia” leads to secondary complications including:
Alternative Treatment: Topical capsaicin cream—the compound that makes chili peppers hot—applied to the abdomen can activate TRPV1 receptors without the burn risk. Emergency departments increasingly use capsaicin cream as a safer alternative to hot water therapy during acute CHS episodes.
While CHS is often dismissed as “just vomiting,” the condition can lead to severe, life-threatening physical complications requiring immediate medical intervention.
Profuse vomiting causes severe dehydration, which can rapidly progress to acute kidney injury. A systematic review found AKI is a frequent CHS complication, often requiring aggressive IV fluid resuscitation. Without prompt treatment, kidney damage can become permanent.
Violent retching can tear the esophageal lining, leading to hematemesis—vomiting blood. These tears constitute a medical emergency requiring immediate intervention to prevent life-threatening hemorrhage.
Loss of potassium and sodium through vomiting disrupts the body’s electrical balance. This can trigger cardiac arrhythmias (irregular heartbeat) and severe muscle spasms. Electrolyte imbalances require careful medical monitoring and IV electrolyte replacement to prevent cardiac complications.
Chronic inability to keep food down leads to dangerous weight loss and long-term nutritional deficiencies. Some CHS patients lose 20-30 pounds during severe episodes, with nutritional consequences that persist even after symptoms resolve.
These complications require the level of medical oversight available in residential settings like Pacific Ridge—not just outpatient therapy. Round-the-clock medical monitoring, IV fluid administration, and supervised nutrition support become essential for managing acute CHS while addressing the underlying Cannabis Use Disorder.

CHS is frequently misdiagnosed as Cyclical Vomiting Syndrome (CVS), gastroenteritis, or anxiety, leading to unnecessary testing, delayed treatment, and continued suffering.
| Characteristic | CHS | CVS |
|---|---|---|
| Cause | Chronic cannabis use | Idiopathic or migraine-related |
| Hot Shower Relief | Highly specific diagnostic sign | Rarely seen |
| Treatment | Complete cannabis cessation | Varies; anti-migraine medications may help |
| Resolution | 48 hours to 1 week after stopping cannabis | Variable; may require ongoing management |
Proper CHS diagnosis requires:
Delayed diagnosis leads to unnecessary CT scans, endoscopies, and colonoscopies—invasive procedures that cost thousands of dollars and expose patients to risk without identifying the problem. Meanwhile, symptoms continue with ongoing cannabis use, and healthcare costs mount while patients suffer needlessly.
While the medical consensus is clear—CHS only resolves with complete cessation of cannabis use—the reality of achieving and maintaining abstinence is complicated by addiction physiology.
Haloperidol: Unlike standard antiemetics, haloperidol (an antipsychotic) shows high efficacy in stopping CHS vomiting in the ER. It works by interacting with dopamine receptors in the brain’s chemoreceptor trigger zone—a different mechanism than traditional anti-nausea medications.
Capsaicin Cream: Topical application to the abdomen activates TRPV1 receptors, providing relief without scalding water. Emergency departments increasingly stock capsaicin cream specifically for CHS treatment.
IV Fluids and Electrolytes: Critical for treating dehydration and electrolyte imbalances that can trigger cardiac complications. Aggressive fluid resuscitation often requires hospital admission during acute episodes.
Symptoms typically resolve within 48 hours to one week of stopping use. However, any re-exposure to cannabis triggers immediate symptom recurrence—there is no “safe” amount of cannabis for someone with CHS history.
Cannabis Use Disorder (CUD): Patients with CHS typically meet DSM-5 criteria for CUD—they’re physically and psychologically dependent on cannabis. The idea of simply “stopping” ignores the reality of addiction.
Withdrawal Symptoms: Cessation triggers irritability, anxiety, insomnia, and decreased appetite—symptoms the patient previously self-medicated with cannabis. Without professional support, these withdrawal symptoms often drive relapse.
The Relapse Cycle: Without structured treatment, patients often relapse to treat withdrawal symptoms, immediately re-triggering CHS. This creates a vicious cycle where physical illness and addiction reinforce each other.
The American Society of Addiction Medicine emphasizes that CHS patients require comprehensive addiction treatment, not just medical management of acute symptoms. Treating the vomiting without addressing the Cannabis Use Disorder virtually guarantees relapse.
Cannabis Hyperemesis Syndrome is no longer a rare medical curiosity—it’s an emerging public health concern in states with legal, high-potency cannabis markets. For long-term marijuana users, particularly those consuming concentrates and high-THC products, CHS represents a real and potentially life-threatening consequence.
The paradox of CHS—where the drug used to treat nausea becomes its cause—highlights the complex relationship between cannabis and the body’s regulatory systems. While cannabis remains a valuable medical tool for some patients, chronic high-dose use can trigger severe physiological dysfunction that only resolves with complete abstinence.
For patients suffering from CHS, the path to recovery requires more than just stopping cannabis use. It requires addressing the underlying Cannabis Use Disorder through comprehensive residential treatment—medical oversight to manage acute complications, supervised detox to navigate withdrawal, and evidence-based therapy to prevent relapse.
If you or someone you know is experiencing severe, cyclical vomiting combined with chronic cannabis use and compulsive hot bathing, it’s time to seek professional help. Pacific Ridge offers the medical expertise and therapeutic support necessary to break the cycle of CHS and achieve lasting recovery.
Don’t let Cannabis Hyperemesis Syndrome control your life. Pacific Ridge’s residential treatment program can help you or a loved one recover from CHS and Cannabis Use Disorder.
References:
Posted in Treatment
Pacific Ridge is a residential drug and alcohol treatment facility about an hour from Portland, Oregon, on the outskirts of Salem. We’re here to help individuals and families begin the road to recovery from addiction. Our clients receive quality care without paying the high price of a hospital. Most of our clients come from Oregon and Washington, with many coming from other states as well.
Pacific Ridge is a private alcohol and drug rehab. To be a part of our treatment program, the client must voluntarily agree to cooperate with treatment. Most intakes can be scheduled within 24-48 hours.
Pacific Ridge is a State-licensed detox and residential treatment program for both alcohol and drugs. We provide individualized treatment options, work closely with managed care organizations, and maintain contracts with most insurance companies.

Quick links
Recent Posts
Contact Us
Pacific Ridge